CLBT
Oof, that’s a rough print
Cellebrite DI, the digital forensics and investigative intelligence software shop, got walloped on Aug. 13 after posting a quarterly earnings miss and cutting full-year 2026 revenue guidance. The stock closed at $10.80, down 29.18% — which is one of those moves that makes your portfolio feel like it stepped on a rake.
Why investors care
This wasn’t just a miss-and-shrug moment. When a company lowers guidance at the same time it misses earnings, the market tends to assume the slowdown isn’t a one-off. Translation: investors start asking whether the growth engine is sputtering, whether demand is softer than expected, or whether the company’s confidence in the second half just took a hit.
The new-CEO subplot
The article also hints that investors are watching what the new CEO does next, which is exactly the kind of plot twist Wall Street loves to obsess over. Fresh leadership can be a reset button — or a very expensive game of musical chairs — depending on whether the next few quarters bring better execution.
Big picture
For now, this is a classic “show me” setup. The company needs to prove that the guidance cut was a speed bump, not a detour. Until then, the stock looks like it’s in the penalty box.